Read the Latest News

Metal Implants and Dental Amalgam: The FDA Announces Public Meeting and Paper

The U.S. Food and Drug Administration (FDA) announced a paper on metal-containing implants and a panel meeting as part of ongoing efforts to evaluate materials in medical devices to address potential safety questions.

Drug Induced Bruxism

The authors of this article state that orofacial movement disorders (bruxism) are treated typically by dental professionals and not by those specialists (neurologists) researching and treating the other movement disorders (Parkinson's disease, Huntington's disease, tremors, etc.). Again, this is more evidence of the complexity of TMD and the need for multidisciplinary research and treatment in TMD.

Cervical Muscle Tenderness in Temporomandibular Disorders and Its Associations with Diagnosis, Disease-Related Outcomes, and Comorbid Pain Conditions

To analyze cervical tenderness scores (CTS) in patients with various temporomandibular disorders (TMD) and in controls and to examine associations of CTS with demographic and clinical parameters.

You, Your Esophagus and TMD

The esophagus is a roughly ten-inch hollow tube that descends from your throat through the diaphragm into the stomach. Normally, it is a one-way street transporting food you swallow to the stomach for digestion. But in GERD— Gastroesophageal Reflux Disease— the flow can reverse so that stomach contents (including gastric acids) are regurgitated upwards to cause a burning sensation (heartburn), nausea, pain and other distressing symptoms.

It's Time to Be Part of the Solution

The National Academy of Medicine (NAM) Study on Temporomandibular Disorders (TMD) is well underway. We strongly encourage everyone affected by TMD to write to the NAM committee letting them know what it is like to live with TMD and your experiences with getting care.

ACTIVITIES AND PROGRAMS

  • Jun 18, 2014

The TMJ Association (TMJA) continues to strive for its ultimate goal: the development of universal standards for safe, effective, affordable, science-based diagnostics, treatments, and prevention of temporomandibular disorders (TMD). We understand that patient education, advocacy, and the provision of accessible support systems are central to achieving that goal.

The TMJA serves patients, professionals, and the general public through a variety of educational, social, and advocacy programs.

  • We represent the needs of patients by participating in government health care policy and research meetings, testifying before congressional committees, and working to promote temporomandibular joint research and development activities in all relevant government agencies. We recognize that educating elected officials is essential to directing attention to the prevalence, cost, and long-term pain and disability often associated with these complex disorders.
  • Our periodicals inform readers of relevant legislative, scientific, and research news. The TMJ Communiqué, a general newsletter, and our TMJ Science journal, a research publication, provide concise, accurate, and newsworthy reports. Our educational materials provide a basic understanding of TMD and related treatment options.
  • We connect TMJ patients in need with other patients who have offered to provide one-on-one support. Our support contacts validate patients' often-doubted pain and disability, reduce isolation, promote self-esteem, and encourage self-reliance and coping skills.
  • The TMJA is shaping a society in which the state of TMD and the pain and suffering they cause are recognized, and effectively managed with scientifically validated treatments.

Back to TMJ Assocation Ltd.

The TMJ Association continues to strive for its ultimate goal: the development of universal standards for safe, effective, affordable, science-based diagnostics, treatments, and prevention of temporomandibular disorders (TMJDs). We understand that patient education, advocacy, and the provision of accessible support systems are central to achieving that goal.

The TMJA serves patients, professionals, and the general public through a variety of educational, social, and advocacy programs:

  • We represent the needs of patients by participating in government health care policy and research meetings, testifying before congressional committees, and working to promote temporomandibular joint research and development activities in all relevant government agencies. We recognize that educating elected officials is essential to directing attention to the prevalence, cost, and long-term pain and disability often associated with these complex disorders.
  • Our periodicals inform readers of relevant legislative, scientific, and research news. The TMJ Communiqué, a general newsletter, and our TMJ Science journal, a research publication, provide concise, accurate, and newsworthy reports. Our educational materials provide a basic understanding of TMJDs and related treatment options.
  • We connect TMJ patients in need with other patients who have offered to provide one-on-one support. Our support contacts validate patients' often-doubted pain and disability, reduce isolation, promote self-esteem, and encourage self-reliance and coping skills.
  • The TMJA is shaping a society in which the state of TMJDs and the pain and suffering they cause are recognized, and effectively managed with scientifically validated treatments.

Back to TMJ Assocation Ltd.